by Alex Acevedo | Sep 4, 2026 | Blog
Choosing Your Route: A Guide to Biologic Administration in Lupus Management For years, managing systemic lupus erythematosus (SLE) relied almost entirely on broad immunosuppressants and daily corticosteroids. Today, targeted biologics have fundamentally shifted...
by Alex Acevedo | Aug 7, 2026 | Blog
Side Effects of Biologic Therapies Biologic therapies, or biotherapies, are medications that are derived from living organisms to treat diseases. They can be produced in a lab or derived from humans or animals to suppress or modify the immune system. They are unlike...
by Alex Acevedo | Jul 1, 2026 | Blog
Currently, the FDA has approved two biologic therapies for systemic lupus and two for lupus nephritis. In addition, there are other off-label options. Many biologic therapies are also under development or in the clinical trials pipeline. This makes it an exciting time...
by Alex Acevedo | Jun 4, 2026 | Blog
Lupus Awareness Month Recap by Chris Milazzo Lupus Awareness Month (LAM) is a powerful annual reminder of the importance of keeping lupus – and everyone it impacts, past and present – at the forefront of our minds. We are in constant awe of our...
by Alex Acevedo | Jun 4, 2026 | Blog
Biologic therapies, or biotherapies, are medications that are derived from living organisms to treat diseases. They can be produced in a lab or derived from humans or animals to suppress or modify the immune system. They are unlike broad-spectrum immunosuppressants...
by Alex Acevedo | Apr 22, 2026 | Blog
Biologics – What Makes Them Different from Immunosuppressives? In 2025, The American College of Rheumatology (ACR) updated their guidelines for the treatment of Systemic Lupus Erythematosus (SLE) with the goal of clinical remission or low disease activity to...
